靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
AN INTERNATIONAL, MULTICENTRE, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TWO DIFFERENT VACCINATION REGIMENS OF IMMUNOTHERAPY WITH ALLOGENEIC DENDRITIC CELLS, DCP-001, IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA THAT ARE IN REMISSION WITH PERSISTENT MRD. - ADVANCE II
100 项与 DCPrime BV 相关的临床结果
0 项与 DCPrime BV 相关的专利(医药)
100 项与 DCPrime BV 相关的药物交易
100 项与 DCPrime BV 相关的转化医学